Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer

Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer - Focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006734

Enrollment

Registered

2011-12-01

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

local relapse case with prostate cancer after radiotherapy

Interventions

high-dose-rate brachytherapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1prostate cancer 2relapse after radiotherapy less than 72Gy 3clinical stage: cT1caN0M0,PSA20ng/ml,anyGS

Exclusion criteria

Exclusion criteria: patients with double cancers patients with hormon refractry patients with unsuitable factors to carry out this salvage HDR-BT

Design outcomes

Primary

Measure	Time frame
side effect	—

Countries

Japan

Contacts

Public ContactJunichi Hiratsuka

Kawasaki Medical School Radiation Oncology

hiratuka@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026